P-294 Comparative effectiveness of teclistamab vs real-world physician's choice of therapy in the LocoMMotion and MoMMent studies for patients with triple-class exposed relapsed/refractory multiple myeloma

Autor: Mateos, Maria-Victoria, van de Donk, Niels, Delforge, Michel, Einsele, Hermann, De Stefano, Valerio, Lindsey-Hill, Joanne, Vincent, Laure, Kirkpatrick, Suriya, Besemer, Britta, Garcia, Maria Esther Gonzalez, Karlin, Lionel, Ghilotti, Francesca, Diels, Joris, Morano, Raúl, Albrecht, Claire, Strulev, Vadim, Haddad, Imène, Pei, Lixia, Kobos, Rachel, Smit, Jennifer, Slavcev, Mary, Marshall, Alexander, Weisel, Katja, Moreau, Philippe
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S199-S199
Databáze: ScienceDirect
Externí odkaz: